Bayer plans to shift focus away from women’s health drug research
Bayer has announced plans to shift its efforts away from women’s health to focus on diseases, cardiovascular disease, neurology, oncology and immunology.
FDA says it's 'working to address' shortage of albuterol product used in hospitals
There is a scarcity of a certain albuterol medication product – and the Food and Drug Administration said Wednesday night that it is "working to address" that.
SOTU: Biden pushes for insulin cost caps
In Tuesday night's State of the Union Address, President Biden called for a cap on the price of insulin.
Narcan maker gets fast-tracked for over-the-counter nasal spray
FDA fast tracks opioid reversing nasal spray, Narcan, for over-the-counter approval, hoping to combat the fentanyl crisis with this life saving medication.
FDA takes tougher line on fast-tracked drugs
The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.
Opioid crisis: New Hampshire strikes $40.5 million settlement with Johnson & Johnson
New Hampshire Attorney General John Formella announced that the state reached a $40.5 million settlement with Johnson & Johnson over opioid claims on Thursday.
West Virginia reaches $400 million settlement with opioid distributors
West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp.
GSK's Generic low-cost HIV prevention drug expected to be ready in 2026
Low-cost preventative HIV medication may be ready as early as 2026, as British pharmaceutical company GSK strikes a deal allowing developing countries access to generic versions.
FDA cautions consumers about honey-based products containing hidden drugs marketed for sexual enhancement
Four companies that produce honey-based products marketed for sexual enhancement were warned by the FDA this week about hidden prescription drugs.
Pfizer recalls some blood pressure drug products over elevated levels of cancer-causing impurity
Pfizer said it was recalling some blood pressure medication and two generic versions Monday over elevated levels of a cancer-causing impurity.
Sacklers willing to pay more in Purdue settlement: mediator
The Sackler family, which owns Purdue Pharma, is willing to contribute more billions to opioid settlements.
Fat burner, growth hormone drugs recalled over product sterility concerns
The Food and Drug Administration (FDA) has announced Innoveix Pharmaceuticals' voluntary recall of two medications over product sterility concerns.
Sen. Cassidy, Warren lead Biogen’s Alzheimer drug Medicare inquiry
Sen. Elizabeth Warren, D-Mass., is leading an effort to examine the Food and Drug Administration's (FDA's) recent approval of a drug to treat Alzheimer's.
Girl's HIV infection seems under control without AIDS drugs
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines.
Ex-CEO's reputation precedes him, affects jury selection
"Pharma Bro" just won't keep his mouth shut.
FDA approves new, cheaper rival to EpiPen allergy shot
U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical greed.
FDA: Avoid fake 'miracle' cancer treatments sold on internet
U.S. regulators are warning consumers to avoid 65 bogus products hawked on the internet with false claims that they can cure, treat or prevent cancer.